학술논문
Antibacterial R&D at a Crossroads: We've Pushed as Hard as We Can ... Now We Need to Start Pulling!
Document Type
Article
Author
Source
Subject
*ANTIBIOTICS
*GRAM-negative bacteria
*INVESTIGATIONAL drugs
*DRUG design
*DRUG resistance in microorganisms
*
*
*
*
Language
ISSN
1058-4838
Abstract
The article offers trends in antibacterial clinical development. It mentions Limited Population Pathway for Antibacterial and Antifungal Drugs as part of the 21st Century Cures Act, focused on approval of new agents specifically for use in patients with unmet medical needs; and also mentions need to buy access to new antibacterial agents as preparedness.